Haploidentical stem cell transplantation in patients with pediatric solid tumors: Preliminary results of a pilot study and analysis of graft versus tumor effects

Klinische Padiatrie

Volumn 218, Issue 6, 2006, Pages 321-326

  Lang, Peter ^a   Pfeiffer, M ^a   Muller I ^a   Schumm, M ^a   Ebinger, M ^a   Koscielniak, E ^b   Feuchtinger, T ^a   Foll J ^c   Martin, D ^a   Handgretinger, R ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b OLGAHOSPITAL   (Germany)

^c MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

GvHD; GvL; Haploidentical transplantation; NK cells; Solid tumors

Indexed keywords

ACICLOVIR; CD19 ANTIGEN; CD3 ANTIGEN; COTRIMOXAZOLE; DEFIBROTIDE; ITRACONAZOLE; METRONIDAZOLE; VORICONAZOLE;

ADULT; ARTICLE; AUTOTRANSPLANTATION; B LYMPHOCYTE; BLOOD DONOR; BLOOD TOXICITY; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DOSE RESPONSE; EWING SARCOMA; FEASIBILITY STUDY; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HAPLOIDY; HUMAN; IN VITRO STUDY; MEDICAL ASSESSMENT; NATURAL KILLER CELL; NEUROBLASTOMA; PILOT STUDY; PROPHYLAXIS; RECURRENT DISEASE; RHABDOMYOSARCOMA; SOLID TUMOR; STEM CELL TRANSPLANTATION; T CELL DEPLETION; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYTOTOXICITY TESTS, IMMUNOLOGIC; DISEASE PROGRESSION; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; GRAFT VS TUMOR EFFECT; HAPLOIDY; HUMANS; KILLER CELLS, NATURAL; NEUROBLASTOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PILOT PROJECTS; RHABDOMYOSARCOMA; SARCOMA, EWING'S; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33845239683     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-942256     Document Type: Article

References (21)

1. Ackermann B, Troger A, Glouchkova L, Korholz D, Gobel U, Dilloo D. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis. Klin Padiatr 2004; 216: 176-182
2. Appelbaum FR. Haematopoietic cell transplantation as immunotherapy. Nature 2001; 411: 385-389
3. Aversa F, Velardi A, Tabilio A, Reisner Y, Martelli MF. Haploidentical stem cell transplantation in leukemia. Blood Rev 2001; 15: 111-119
4. Blaise D, Bay JO, Faucher C, Michallet M, Boiron JM, Choufi B, Cahn JY, Gratecos N, Sotto JJ, Francois S, Fleury J, Mohty M, Chabannon C, Bilger K, Gravis G, Viret F, Braud AC, Bardou VJ, Maraninchi D, Viens P. Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors. Blood 2004; 103: 435-441
5. Burdach S, van Kaick B, Laws HJ, Ahrens S, Haase R, Korholz D, Pape H, Dunst J, Kahn T, Willers R, Engel B, Dirksen U, Kramm C, Nurnberger W, Heyll A, Ladenstein R, Gadner H, Jurgens H, Go EU. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Dusseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria. Ann Oncol 2000; 11: 1451-1462
6. Carli M, Colombatti R, Oberlin O, Stevens M, Masiero L, Frascella E, Koscielniak E, Treuner J, Pinkerton CR. High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma. J Clin Oncol 1999; 17: 2796-2803
7. Creutzig U, Jurgens H, Herold R, Gobel U, Henze G. [Concepts of the Society of Paediatric Oncology and Haematology (GPOH) and the German Competence Network in Paediatric Oncology and Haematology for the quality controlled development in paediatric oncology]. Klin Padiatr 2004; 216: 379-383
8. Feuchtinger T, Richard C, Pfeiffer M, Neuhauser F, Lucke J, Handgretinger R, Greil J, Bader P, Klingebiel T, Schlegel PG, Jahn G, Niethammer D, Lang P. Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update. Klin Padiatr 2005; 217: 339-344
9. Gobel U. [One group ticket "from bench to bedside", return, please!]. Klin Padiatr 2005; 217: 307-309
10. Handgretinger R, Anderson K, Lang P, Dopfer R, Klingebiel T, Schrappe M, Reuland P, Gillies SD, Reisfeld RA, Neithammer D. A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma. Eur J Cancer 1995; 31A: 261-267
11. Handgretinger R, Bruchelt G, Daurer B, Lang P, Herter M, Dopfer R, Muller B, Reisfeld RA, Treuner J, Niethammer D. The role of interferon-gamma in the immunotherapy of neuroblastoma. Prog Clin Biol Res 1991; 366: 401-407
12. Handgretinger R, Klingebiel T, Lang P, Schumm M, Neu S, Geiselhart A, Bader P, Schlegel PG, Greil J, Stachel D, Herzog RJ, Niethammer D. Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 2001; 27: 777-783
13. Koscielniak E, Klingebiel TH, Peters C, Hermann J, Burdach ST, Bender-Gotze C, Muller-Weihrich ST, Treuner J. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. Bone Marrow Transplant 1997; 19: 227-231
14. Lang P, Greil J, Bader P, Handgretinger R, Klingebiel T, Schumm M, Schlegel PG, Feuchtinger T, Pfeiffer M, Scheel-Walter H, Fuhrer M, Martin D, Niethammer D. Long-term outcome after haploidentical stem cell transplantation in children. Blood Cells Mol Dis 2004; 33: 281-287
15. Lang P, Schumm M, Greil J, Bader P, Klingebiel T, Muller I, Feuchtinger T, Pfeiffer M, Schlegel PG, Niethammer D, Handgretinger R. A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study. Klin Padiatr 2005; 217: 334-338
16. Langler A, Christaras A, Abshagen K, Krauth K, Hero B, Berthold F. Topotecan in the treatment of refractory neuroblastoma and other malignant tumors in childhood - a phase-II-study. Klin Padiatr 2002; 214: 153-156
17. Raffaghello L, Prigione I, Bocca P, Morandi F, Camoriano M, Gambini C, Wang X, Ferrone S, Pistoia V. Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications. Oncogene 2005; 24: 4634-4644
18. Recchia F, Cesta A, Rea S. Low dose interleukin-2 and 13-cis-retinoic acid as maintenance therapy in patients with solid tumors responsive to chemotherapy. J Exp Clin Cancer Res 2003; 22: 135-143
19. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097-2100
20. Saylors III RL, Stine KC, Sullivan J, Kepner JL, Wall DA, Bernstein ML, Harris MB, Hayashi R, Vietti TJ. Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study. J Clin Oncol 2001; 19: 3463-3469
21. Simon T, Hero B, Faldum A, Handgretinger R, Schrappe M, Niethammer D, Berthold F. Consolidation treatment with chimeric anti-GD2-antibody ch14.18 in children older than 1 year with metastatic neuroblastoma. J Clin Oncol 2004; 22: 3549-3557